CV Therapeutics, Inc. (NASDAQ: CVTX) announced today that an analysis of unblinded data from the MERLIN TIMI-36 study of ranolazine shows there was no adverse trend in death or arrhythmias in patients on ranolazine. The study did not meet the primary efficacy endpoint.
Drinking a specially-made cocoa beverage daily may have the potential to reverse impairments in the functioning of blood vessels, according to a first-of-its-kind study published in the Journal of Cardiovascular Pharmacology.
For the first time in humans, scientists have found early indicators of inflammation ? potential warning signs ? in work-related injuries caused by repetitive motion. Their findings could someday lead to early detection and prevention of debilitating conditions such as carpal tunnel syndrome and tendonitis.
High-temperature superconductors hold the key to a handheld tool for surgeons that promises to be more accurate, cost-effective and safer than existing methods for staging and treating various cancers, including breast cancer.
Blood tests for panic disorder and other mental health conditions are potentially around the corner, based on results from a University of Iowa study. The findings, which were based on analysis of genetic information in lymphoblasts, or immature white blood cells, appear online March 6 in the American Journal of Medical Genetics.
As part of its continuing effort to highlight the critical role that laboratory medicine plays in healthcare, Abbott announced that it has awarded diagnostic equipment, supplies and service to clinical laboratory educational programs at 16 accredited schools across the United States.
Children in the United States suffer from asthma more than any other chronic illness, and new research finds African-American children with the condition have a greater risk than others of experiencing severe symptoms that escalate into an emergency.
The Honourable Tony Clement, Minister of Health, launched during a FITMOM Canada class in Ottawa, a five-week national Healthy Pregnancy Campaign to raise awareness of the health considerations for a healthy pregnancy.
Novo Nordisk announced that the European Commission has approved Levemir? (insulin detemir) for once-daily use in combination with oral antidiabetic drugs (OADs).
Researchers at the University of Arizona College of Medicine?s Department of Immunobiology have discovered that the agent that causes tuberculosis (TB), Mycobacterium tuberculosis, produces a new type of virulence factor called Mycobacterium Tuberculosis Pili (MTP). Their findings suggest that MTP could be a promising, new TB-vaccine candidate. Worldwide, three million people die each year from tuberculosis and an estimated 1.2 billion are infected with the bacteria.